ACADIA PHARMACEUTICALS INC. Amortization of Intangible Assets
ACADIA PHARMACEUTICALS INC. (ACAD) reported Amortization of Intangible Assets of $5.45 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-05
- ACADIA PHARMACEUTICALS INC. amortization of intangible assets for the quarter ending 2026-06-30 was $2.72M, a 0.04% increase year-over-year.
- ACADIA PHARMACEUTICALS INC. amortization of intangible assets for the quarter ending 2026-03-31 was $2.72M, a 0.00% change year-over-year.
- ACADIA PHARMACEUTICALS INC. amortization of intangible assets for the quarter ending 2025-12-31 was $2.72M, a 45.43% decline year-over-year.
- ACADIA PHARMACEUTICALS INC. amortization of intangible assets for the quarter ending 2025-09-30 was $2.72M, a 16.17% increase year-over-year.
- ACADIA PHARMACEUTICALS INC. amortization of intangible assets for fiscal 2025 was $10.89M, a 27.23% decline from fiscal 2024.
- ACADIA PHARMACEUTICALS INC. amortization of intangible assets for fiscal 2024 was $14.96M, a 265.58% increase from fiscal 2023.
- ACADIA PHARMACEUTICALS INC. amortization of intangible assets for fiscal 2023 was $4.09M.
- ACADIA PHARMACEUTICALS INC. amortization of intangible assets for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $5.45M 10-Q · filed 2026-08-05 | $8.17M derived: sum of 3 quarters · filed 2026-08-05 | $10.89M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $2.72M 10-Q · filed 2026-05-07 | $5.44M derived: sum of 2 quarters · filed 2026-05-07 | $8.17M derived: sum of 3 quarters · filed 2026-05-07 | $10.89M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $2.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.45M derived: sum of 2 quarters · filed 2026-02-26 | $8.17M derived: sum of 3 quarters · filed 2026-08-05 | $10.89M 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $5.45M derived: sum of 2 quarters · filed 2026-08-05 | $8.17M 10-Q · filed 2025-11-06 | $13.15M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $2.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $5.44M 10-Q · filed 2026-08-05 | $10.43M derived: sum of 3 quarters · filed 2026-08-05 | $12.78M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $2.72M 10-Q · filed 2026-05-07 | $7.71M derived: sum of 2 quarters · filed 2026-05-07 | $10.05M derived: sum of 3 quarters · filed 2026-05-07 | $12.40M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $4.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $7.33M derived: sum of 2 quarters · filed 2026-02-26 | $9.68M derived: sum of 3 quarters · filed 2026-02-26 | $14.96M 10-K · filed 2026-02-26 |
| 2024-09-30 | $2.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $4.69M derived: sum of 2 quarters · filed 2025-11-06 | $9.97M 10-Q · filed 2025-11-06 | $11.34M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $2.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $7.63M 10-Q · filed 2025-08-07 | $9.00M derived: sum of 3 quarters · filed 2026-02-26 | $10.36M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $5.29M 10-Q · filed 2025-05-08 | $6.65M derived: sum of 2 quarters · filed 2026-02-26 | $8.02M derived: sum of 3 quarters · filed 2026-02-26 | $9.38M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.73M derived: sum of 2 quarters · filed 2026-02-26 | $4.09M derived: sum of 3 quarters · filed 2026-02-26 | $4.09M 10-K · filed 2026-02-26 |
| 2023-09-30 | $1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.73M derived: sum of 2 quarters · filed 2024-11-07 | $2.73M 10-Q · filed 2024-11-07 | $2.73M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $1.36M 10-Q · filed 2024-08-07 | $1.36M derived: sum of 3 quarters · filed 2025-02-27 | $1.36M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $0.00 derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $0.00 derived: sum of 2 quarters · filed 2023-11-03 | $0.00 10-Q · filed 2023-11-03 | $0.00 derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $0.00 10-Q · filed 2023-08-03 | $0.00 derived: sum of 3 quarters · filed 2024-02-28 | $400.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-05 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | $400.00K derived: sum of 3 quarters · filed 2024-02-28 | $800.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $400.00K derived: sum of 2 quarters · filed 2024-02-28 | $800.00K derived: sum of 3 quarters · filed 2024-02-28 | $1.11M 10-K · filed 2024-02-28 |
| 2021-09-30 | $400.00K 10-Q · filed 2021-11-09 | $800.00K derived: sum of 2 quarters · filed 2021-11-09 | $1.11M 10-Q · filed 2022-11-03 | $1.54M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $400.00K 10-Q · filed 2021-08-05 | $739.00K 10-Q · filed 2022-08-09 | $1.14M derived: sum of 3 quarters · filed 2023-02-28 | $1.54M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $370.00K 10-Q · filed 2022-05-05 | $739.00K derived: sum of 2 quarters · filed 2023-02-28 | $1.14M derived: sum of 3 quarters · filed 2023-02-28 | $1.54M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $369.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $769.00K derived: sum of 2 quarters · filed 2023-02-28 | $1.17M derived: sum of 3 quarters · filed 2023-02-28 | $1.48M 10-K · filed 2023-02-28 |
| 2020-09-30 | $400.00K 10-Q · filed 2020-11-04 | $800.00K derived: sum of 2 quarters · filed 2020-11-04 | $1.11M 10-Q · filed 2021-11-09 | $1.54M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $400.00K 10-Q · filed 2020-08-06 | $739.00K 10-Q · filed 2021-08-05 | $1.14M derived: sum of 3 quarters · filed 2022-03-01 | $1.54M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $370.00K 10-Q · filed 2021-05-06 | $739.00K derived: sum of 2 quarters · filed 2022-03-01 | $1.14M derived: sum of 3 quarters · filed 2022-03-01 | $1.54M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $369.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $769.00K derived: sum of 2 quarters · filed 2022-03-01 | $1.17M derived: sum of 3 quarters · filed 2022-03-01 | $1.48M 10-K · filed 2022-03-01 |
| 2019-09-30 | $400.00K 10-Q · filed 2020-11-04 | $800.00K derived: sum of 2 quarters · filed 2020-11-04 | $1.11M 10-Q · filed 2020-11-04 | $1.54M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $400.00K 10-Q · filed 2020-08-06 | $739.00K 10-Q · filed 2020-08-06 | $1.14M derived: sum of 3 quarters · filed 2021-02-25 | $1.54M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $370.00K 10-Q · filed 2020-05-08 | $739.00K derived: sum of 2 quarters · filed 2021-02-25 | $1.14M derived: sum of 3 quarters · filed 2021-02-25 | $1.54M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $369.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $769.00K derived: sum of 2 quarters · filed 2021-02-25 | $1.17M derived: sum of 3 quarters · filed 2021-02-25 | $1.48M 10-K · filed 2021-02-25 |
| 2018-09-30 | $400.00K 10-Q · filed 2019-10-31 | $800.00K derived: sum of 2 quarters · filed 2019-10-31 | $1.11M 10-Q · filed 2019-10-31 | $1.54M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $400.00K 10-Q · filed 2019-08-01 | $738.00K 10-Q · filed 2019-08-01 | $1.14M derived: sum of 3 quarters · filed 2020-02-27 | $1.54M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $369.00K 10-Q · filed 2019-05-02 | $738.00K derived: sum of 2 quarters · filed 2020-02-27 | $1.14M derived: sum of 3 quarters · filed 2020-02-27 | $1.54M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $369.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $769.00K derived: sum of 2 quarters · filed 2020-02-27 | $1.17M derived: sum of 3 quarters · filed 2020-02-27 | $1.48M 10-K · filed 2020-02-27 |
| 2017-09-30 | $400.00K 10-Q · filed 2018-11-06 | $800.00K derived: sum of 2 quarters · filed 2018-11-06 | $1.11M 10-Q · filed 2018-11-06 | $1.54M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $400.00K 10-Q · filed 2018-08-08 | $738.00K 10-Q · filed 2018-08-08 | $1.14M derived: sum of 3 quarters · filed 2019-02-27 | $1.51M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $369.00K 10-Q · filed 2018-05-04 | $739.00K derived: sum of 2 quarters · filed 2019-02-27 | $1.11M derived: sum of 3 quarters · filed 2019-02-27 | $1.35M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $370.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $739.00K derived: sum of 2 quarters · filed 2019-02-27 | $985.00K derived: sum of 3 quarters · filed 2019-02-27 | $985.00K 10-K · filed 2019-02-27 |
| 2016-09-30 | $369.00K 10-Q · filed 2016-11-07 | $615.00K derived: sum of 2 quarters · filed 2016-11-07 | $615.00K 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $246.00K 10-Q · filed 2016-08-04 | $246.00K 10-Q · filed 2017-08-08 | ||
| 2015-12-31 | $0.00 10-K · filed 2018-02-27 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |